全文获取类型
收费全文 | 368758篇 |
免费 | 33669篇 |
国内免费 | 25882篇 |
专业分类
耳鼻咽喉 | 3514篇 |
儿科学 | 3950篇 |
妇产科学 | 5294篇 |
基础医学 | 43634篇 |
口腔科学 | 6226篇 |
临床医学 | 50586篇 |
内科学 | 54430篇 |
皮肤病学 | 3468篇 |
神经病学 | 20197篇 |
特种医学 | 13896篇 |
外国民族医学 | 231篇 |
外科学 | 38228篇 |
综合类 | 60816篇 |
现状与发展 | 85篇 |
一般理论 | 23篇 |
预防医学 | 23700篇 |
眼科学 | 10418篇 |
药学 | 37843篇 |
383篇 | |
中国医学 | 20562篇 |
肿瘤学 | 30825篇 |
出版年
2024年 | 1164篇 |
2023年 | 5655篇 |
2022年 | 14783篇 |
2021年 | 18376篇 |
2020年 | 13596篇 |
2019年 | 11870篇 |
2018年 | 12680篇 |
2017年 | 11348篇 |
2016年 | 10592篇 |
2015年 | 16347篇 |
2014年 | 20330篇 |
2013年 | 18108篇 |
2012年 | 26815篇 |
2011年 | 30183篇 |
2010年 | 19292篇 |
2009年 | 15140篇 |
2008年 | 20170篇 |
2007年 | 20099篇 |
2006年 | 19756篇 |
2005年 | 19150篇 |
2004年 | 12211篇 |
2003年 | 11073篇 |
2002年 | 9425篇 |
2001年 | 8274篇 |
2000年 | 8970篇 |
1999年 | 9537篇 |
1998年 | 5778篇 |
1997年 | 5777篇 |
1996年 | 4542篇 |
1995年 | 4133篇 |
1994年 | 3350篇 |
1993年 | 2207篇 |
1992年 | 2947篇 |
1991年 | 2529篇 |
1990年 | 2210篇 |
1989年 | 1918篇 |
1988年 | 1642篇 |
1987年 | 1424篇 |
1986年 | 1159篇 |
1985年 | 953篇 |
1984年 | 557篇 |
1983年 | 383篇 |
1982年 | 256篇 |
1981年 | 247篇 |
1980年 | 192篇 |
1979年 | 232篇 |
1978年 | 90篇 |
1977年 | 91篇 |
1974年 | 112篇 |
1972年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
目的:通过研究风险评估工具,结合企业临床试验数据管理风险评估实例,从实际应用角度出发,提出完善药物临床试验数据管理过程中应用风险评估的意见建议。方法:运用文献分析方法、案例分析法,分析和借鉴成功的经验。结果与结论:我国的药品研制单位应根据具体临床试验特点和法规要求,利用合适的风险管理工具,对临床试验数据管理过程进行评估,根据评估结果合理制定并实施数据管理策略,达到保证临床试验数据完整、可靠的目的。 相似文献
92.
93.
Jennifer Wang Jonathan G. Stine Scott L. Cornella Curtis K. Argo Steven M. Cohn 《临床与转化肝病杂志(英文版)》2015,3(4):254-259
Background and Aims: Gastric antral vascular ectasia (GAVE) is commonly found in patients with cirrhosis, but it is also associated with other diseases in the absence of cirrhosis. Whether GAVE confers a different severity of gastrointestinal (GI) bleeding between patients with and without cirrhosis remains unknown. We aim to examine whether there is a difference in clinically significant GI bleeding due to GAVE in patients with or without cirrhosis. Methods: This is a retrospective case-control study of patients who were diagnosed with GAVE between January 2000 and June 2014. Patients were categorized into cirrhosis and noncirrhosis groups, and those with an additional GI bleeding source were excluded. Univariate comparisons and multivariable models were constructed using logistic regression. Results: In total, 110 patients diagnosed with GAVE on esophagogastroduodenoscopy (EGD) were included in our analysis; 84 patients had cirrhosis (76.4%) and 26 (23.6%) did not. Active GI bleeding was more prevalent in patients without cirrhosis (63.4% vs. 32.1%, p=0.003) despite similar indications for EGD, and endoscopic treatment with argon plasma coagulation (APC) was required more often in this group, approaching statistical significance (27% vs. 10.7%, p=0.056). There was no difference in bleeding severity, as evidenced by similar re-bleeding rates, surgery, or death attributed to uncontrolled bleeding. The strongest independent risk factor for GI bleeding was the absence of cirrhosis (odds ratio (OR): 5.151 (95% confidence interval (CI): 1.08-24.48, p=0.039). Conclusions: Patients with GAVE in the absence of cirrhosis are at higher risk for active GI bleeding and require more frequent endoscopic treatment than similar patients with cirrhosis. It may be worthwhile to treat GAVE in this population even in the absence of active bleeding. 相似文献
94.
95.
96.
Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer’s Disease
In order to solve the problem of long-term (>9 months) efficacy in the treatment of Alzheimer''s disease (AD) by conventional therapy (CT), a staged and multiply-targeted sequential therapy based on the evolvement of patterns (STEP) was developed. Its main innovations include: (1) the time order of evolution of patterns defined by Chinese medicine (CM) in AD was found, that is, "the orderly pattern evolution starting from Shen (Kidney) deficiency, progressing to phlegm, stasis and fire, and worsening to severe toxin as well as functional collapse"; (2) the cascade hypothesis of Shen deficiency in AD and its sequential therapy based on Shen-reinforcing was proposed, that is, "reinforcing Shen in the early stage and throughout the whole process, resolving phlegm, activating blood and purging fire in the middle stage, detoxifying and replenishing vitality to stop the collapse in the advanced stage", and through meta-analysis, clinical drug use was optimized, thus the leap from "inferential selection" to "evidence-based selection" was realized; (3) the STEP regimen combined with CT maintained cognitive and behavioral stability in AD patients for at least 12 months, with cognitive enhancement and behavioral synergy after 9 months, and cognitive benefit was superior to CT at 9, 12, 15, 18, 21, and 24 months, respectively. The 2-year cognitive improvement rate was increased by 25.64% (P=0.020) and the cognitive deterioration rate was decreased by 48.71% (P=0.000). Among them, the cognitive and functional benefits of Shen-reinforcing therapy for very early AD (350 cases) for 1 year were better than the placebo (P<0.001), and the dementia conversion rate was reduced by 8.85% (P=0.002). The behavioral symptomatic relief of patients with vascular dementia received fire-purging therapy (540 cases) was superior to those received CT (P=0.016). These data suggested that the STEP regimen has synergistic effects on CTs at least in terms of cognitive benefit, and the earlier the use, the greater the benefit will have. Therefore, the STEP regimen should be considered as one of the clinical options, particularly for the dearth of effective pharmaceutical or immunological interventions that are currently available for AD. 相似文献
97.
Shisong Zhang Juan Li Yurui Wu Yuanjun Hu Chunhong Duan Meiyun Wang Zhongtao Gai 《Medicine》2015,94(39)
The purpose of this meta-analysis is to compare the relative merits among laparoscopic-assisted operations and laparotomy operations for patients with Hirschsprung disease.PubMed, Web of Science, and Wanfang databases were searched for the related articles. We analyzed dichotomous variables by estimating odds ratios (ORs) with their 95% confidence intervals (CIs) and continuous variables using the weighted mean difference (WMD) with the 95% CI. The random-effects model (REM) was used to combine the results. The outcome measures included operating time (OT), estimated blood loss (EBL), length of hospital stay (LOHS), mean first bowel movement (MFBM), and number of complications.Sixteen articles were included in the meta-analysis. These studies involved a total of 774 patients, 396 of whom underwent laparoscopic-assisted operations and 378 of whom underwent laparotomy operations. The EBL (WMD = −1.48, 95% CI = −1.82, −1.13), LOHS (WMD = −0.67, 95% CI = −0.86, −0.49), MFBM (WMD = −0.83, 95% CI = −1.05, −0.61), and number of complications (OR = 0.60, 95% CI = 0.40, 0.89) were significantly lower in laparoscopic-assisted operations than in laparotomy operations. The OT (WMD = 0.12, 95% CI = −0.05, 0.28) showed no significant differences between laparoscopic-assisted operations and laparotomy operations.Compared with laparotomy operations, laparoscopic-assisted operations are generally safer and more reliable for patients with Hirschsprung disease. 相似文献
98.
99.
100.